Scott Koenig - 15 Feb 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: President and CEO, Director
Signature: /s/ Lynn M. Cilinski, Attorney-in-fact
Issuer symbol: MGNX
Transactions as of: 15 Feb 2024
Net transactions value: -$249,673
Form type: 4
Filing time: 20 Feb 2024, 18:04:58 UTC
Previous filing: 12 Feb 2024
Next filing: 01 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Options Exercise	$0	+42,341	+4%	$0.000000	1,091,977	15 Feb 2024	Direct	F1
transaction	MGNX	Common Stock	Tax liability	$249,673	-14,349	-1.3%	$17.40	1,077,628	15 Feb 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Restricted Stock Unit	Options Exercise	$0	-42,341	-33%	$0.000000	84,659	15 Feb 2024	Common Stock	42,341	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.